These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 27672297

  • 1. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C, Herath CB, Jia Z, Andrikopoulos S, Brown BE, Davies MJ, Rivera LR, Furness JB, Forbes JM, Angus PW.
    World J Gastroenterol; 2016 Sep 21; 22(35):8026-40. PubMed ID: 27672297
    [Abstract] [Full Text] [Related]

  • 2. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
    Leung C, Herath CB, Jia Z, Goodwin M, Mak KY, Watt MJ, Forbes JM, Angus PW.
    J Hepatol; 2014 Apr 21; 60(4):832-8. PubMed ID: 24316518
    [Abstract] [Full Text] [Related]

  • 3. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
    Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ.
    Hepatology; 2010 Sep 21; 52(3):934-44. PubMed ID: 20607689
    [Abstract] [Full Text] [Related]

  • 4. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y, Yamaguchi K, Nakajima T, Nishikawa T, Jo M, Mitsumoto Y, Kimura H, Nishimura T, Tochiki N, Yasui K, Mitsuyoshi H, Minami M, Kagawa K, Okanoue T, Itoh Y.
    Liver Int; 2013 Feb 21; 33(2):301-11. PubMed ID: 23295058
    [Abstract] [Full Text] [Related]

  • 5. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, Kodys K, Szabo G.
    J Transl Med; 2015 Jun 16; 13():193. PubMed ID: 26077675
    [Abstract] [Full Text] [Related]

  • 6. Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    Pereira ENGDS, Silvares RR, Flores EEI, Rodrigues KL, Ramos IP, da Silva IJ, Machado MP, Miranda RA, Pazos-Moura CC, Gonçalves-de-Albuquerque CF, Faria-Neto HCC, Tibiriça E, Daliry A.
    PLoS One; 2017 Jun 16; 12(6):e0179654. PubMed ID: 28628674
    [Abstract] [Full Text] [Related]

  • 7. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P, Aloman C, Ankireddy A, Khadra H, Ooka K, Gill RK, Saksena S, Dudeja PK, Alrefai WA.
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov 01; 313(5):G376-G385. PubMed ID: 28774869
    [Abstract] [Full Text] [Related]

  • 8. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
    Ye D, Li FY, Lam KS, Li H, Jia W, Wang Y, Man K, Lo CM, Li X, Xu A.
    Gut; 2012 Jul 01; 61(7):1058-67. PubMed ID: 22253482
    [Abstract] [Full Text] [Related]

  • 9. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet.
    Kamada Y, Kiso S, Yoshida Y, Chatani N, Kizu T, Hamano M, Tsubakio M, Takemura T, Ezaki H, Hayashi N, Takehara T.
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec 01; 301(6):G1031-43. PubMed ID: 21885686
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
    Hoo RL, Lee IP, Zhou M, Wong JY, Hui X, Xu A, Lam KS.
    J Hepatol; 2013 Feb 01; 58(2):358-64. PubMed ID: 23108115
    [Abstract] [Full Text] [Related]

  • 11. Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.
    Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB.
    J Nutr; 2012 Aug 01; 142(8):1495-503. PubMed ID: 22739374
    [Abstract] [Full Text] [Related]

  • 12. Lindera obtusiloba Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by Nε-(carboxymethyl)lysine.
    Lee JA, Gu MJ, Lee YR, Kim Y, Choi I, Kim D, Ha SK.
    Nutrients; 2024 Jul 19; 16(14):. PubMed ID: 39064772
    [Abstract] [Full Text] [Related]

  • 13. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA, Sheldon RD, Meers GM, Ortinau LC, Morris EM, Booth FW, Kanaley JA, Vieira-Potter VJ, Sowers JR, Ibdah JA, Thyfault JP, Laughlin MH, Rector RS.
    J Physiol; 2016 Sep 15; 594(18):5271-84. PubMed ID: 27104887
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products.
    Fernando DH, Forbes JM, Angus PW, Herath CB.
    Int J Mol Sci; 2019 Oct 11; 20(20):. PubMed ID: 31614491
    [Abstract] [Full Text] [Related]

  • 17. [Sivelestat alleviates nonalcoholic steatohepatitis in mice through inhibiting activation of Kupffer cells].
    Zang SF, Ma XJ, Wang L, Zhu GL, Yang WJ, Liu YL, Yan J, Luo Y, Zhuang ZJ, Chen JY, Xun YH, Shi JP.
    Zhonghua Gan Zang Bing Za Zhi; 2017 May 20; 25(5):371-376. PubMed ID: 28763845
    [Abstract] [Full Text] [Related]

  • 18. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Lytle KA, Jump DB.
    PLoS One; 2016 May 20; 11(1):e0146942. PubMed ID: 26761430
    [Abstract] [Full Text] [Related]

  • 19. Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis.
    Marin V, Gazzin S, Gambaro SE, Dal Ben M, Calligaris S, Anese M, Raseni A, Avellini C, Giraudi PJ, Tiribelli C, Rosso N.
    Nutrients; 2017 Sep 12; 9(9):. PubMed ID: 28895929
    [Abstract] [Full Text] [Related]

  • 20. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ.
    BMC Gastroenterol; 2019 Mar 18; 19(1):41. PubMed ID: 30885145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.